Anagenics Ltd

NEW
ASX:AN1 (Australia)  
A$ 0.0070 (0%) Jun 26
At Loss
P/B:
3.50
Market Cap:
A$ 6.90M ($ 4.86M)
Enterprise V:
A$ 7.59M ($ 5.35M)
Volume:
89.33K
Avg Vol (2M):
666.26K
Trade In:
Volume:
89.33K
At Loss
Avg Vol (2M):
666.26K

Business Description

Description
Anagenics Ltd is a health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. It develops and sells differentiated and clinically validated solutions for a range of conditions associated with aging. It includes validated consumer products to help people live longer, in good health, and with confidence. Its brands include Evolis and Uspa.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
0.3
Equity-to-Asset
0.56
Debt-to-Equity
0.43
Debt-to-EBITDA
-2.7
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-20.34
Distress
Grey
Safe
Beneish M-Score
-1.35
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
63.02
9-Day RSI
57.99
14-Day RSI
55.5
3-1 Month Momentum %
40
6-1 Month Momentum %
40
12-1 Month Momentum %
75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.1
Quick Ratio
0.56
Cash Ratio
0.16
Days Inventory
146.07
Days Sales Outstanding
51.36
Days Payable
152.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-30.5
Shareholder Yield %
-8.11

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
40.38
Operating Margin %
-15.1
Net Margin %
-15.36
EBITDA Margin %
-8.72
FCF Margin %
-22.7
OCF Margin %
-22.44
ROE %
-30.48
ROA %
-15.48
ROIC %
-21.32
3-Year ROIIC %
-60.05
ROC (Joel Greenblatt) %
-92.74
ROCE %
-25.88

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
0.88
PB Ratio
3.5
EV-to-EBIT
-13.29
EV-to-EBITDA
-20.74
EV-to-Revenue
1.81
EV-to-Forward-Revenue
0.58
EV-to-FCF
-7.97
Price-to-Median-PS-Value
0.7
Earnings Yield (Greenblatt) %
-7.52
FCF Yield %
-13.82

Financials

ASX:AN1's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Anagenics Ltd Executives

Details

GF Value™

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 4.198
EPS (TTM) (A$) -0.002
Beta 0.0746
3-Year Sharpe Ratio -0.58
3-Year Sortino Ratio -0.69
Volatility % 51
14-Day RSI 55.5
14-Day ATR (A$) 0.000401
20-Day SMA (A$) 0.00645
12-1 Month Momentum % 75
52-Week Range (A$) 0.004 - 0.009
Shares Outstanding (Mil) 985.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anagenics Ltd Filings

Filing Date Document Date Form
No Filing Data

Anagenics Ltd Stock Events

Financials Calendars
Event Date Price (A$)
0.05:1 Stock Split 2017-11-27 0.35 (-5.00%)
Show
Entries

Anagenics Ltd Frequently Asked Questions

What is Anagenics Ltd(ASX:AN1)'s stock price today?
The current price of ASX:AN1 is A$0.01. The 52 week high of ASX:AN1 is A$0.01 and 52 week low is A$0.00.
When is next earnings date of Anagenics Ltd(ASX:AN1)?
The next earnings date of Anagenics Ltd(ASX:AN1) is .
Does Anagenics Ltd(ASX:AN1) pay dividends? If so, how much?
Anagenics Ltd(ASX:AN1) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Anagenics Ltd

No articles.